Compare CODX & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODX | VRAR |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | 40 |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 17.2M |
| IPO Year | 2017 | 2021 |
| Metric | CODX | VRAR |
|---|---|---|
| Price | $0.18 | $0.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.25 | ★ $2.62 |
| AVG Volume (30 Days) | ★ 1.6M | 129.7K |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $507,892.00 | ★ $9,488,209.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.89 | $72.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.60 |
| 52 Week Low | $0.22 | $0.77 |
| 52 Week High | $1.55 | $3.14 |
| Indicator | CODX | VRAR |
|---|---|---|
| Relative Strength Index (RSI) | 30.03 | 36.26 |
| Support Level | $0.22 | $0.77 |
| Resistance Level | $0.30 | $0.88 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 2.05 | 21.49 |
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.